Related Experiment Video

Updated: Jun 5, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Nonalcoholic fatty liver disease in children

Ali A Mencin1, Joel E Lavine

  • 1Division of Pediatric Gastroenterology, Columbia University Medical Center, New York, New York, USA.

Current Opinion in Clinical Nutrition and Metabolic Care
|December 24, 2010
PubMed

Insights

Nonalcoholic fatty liver disease (NAFLD) is a growing concern in children, often underdiagnosed and potentially leading to cirrhosis. Research is advancing in noninvasive diagnostics and understanding genetic and environmental factors for better pediatric NAFLD management.

Area of Science:

  • Pediatrics
  • Hepatology
  • Genetics

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children in developed countries.
  • Pediatric NAFLD is frequently underdiagnosed and can progress to severe liver damage, including cirrhosis.
  • This condition shares similarities with adult NAFLD but is recognized as a distinct entity requiring specific research.

Purpose of the Study:

  • To provide a focused overview of pediatric NAFLD.
  • To summarize recent advancements in the diagnosis and understanding of pediatric NAFLD.
  • To highlight the need for further investigation into pathophysiology and therapeutic targets.

Main Methods:

  • Review of current literature on pediatric NAFLD.
  • Discussion of diagnostic tools, including liver biopsy and emerging noninvasive biomarkers/imaging.
  • Analysis of genetic factors (e.g., PNPLA3 gene), dietary influences, gut microbiota, and hormonal modulators.

Main Results:

  • Pediatric NAFLD can cause significant liver injury, including cirrhosis.
  • Noninvasive diagnostic methods show promise alongside traditional liver biopsy.
  • Genetic predisposition, particularly the PNPLA3 gene allele, is strongly associated with NAFLD.
  • Diet, gut flora, and sex hormones are implicated in disease modulation.
  • Current treatment focuses on diet and exercise, with vitamin E as a potential adjunct.

Conclusions:

  • Pediatric NAFLD is a unique condition distinct from adult NAFLD.
  • Epidemiology and risk factors are better understood, but pathophysiology requires more research.
  • Novel therapeutic targets for pediatric NAFLD need to be identified.
Abstract

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...